202 related articles for article (PubMed ID: 15149670)
1. Potential hypotensive agents: synthesis and hypotensive activity of oxime ethers derived from 1-naphthoxepines and related compounds.
Tandon VK; Kumar M; Awasthi AK; Saxena HO; Goswamy GK
Bioorg Med Chem Lett; 2004 Jun; 14(12):3177-80. PubMed ID: 15149670
[TBL] [Abstract][Full Text] [Related]
2. Studies in hypotensive agents. Synthesis and hypotensive activity of 3,4-dihydro-1(2H)-benzoxepine oxime ethers and their derivatives.
Tandon VK; Chandra A; Dua PR; Srimal RC
Arch Pharm (Weinheim); 1993 Apr; 326(4):221-5. PubMed ID: 8494484
[TBL] [Abstract][Full Text] [Related]
3. 1- and 2-substituted naphthalenes: a new class of potential hypotensive agents.
Tandon VK; Singh KA; Goswamy GK
Bioorg Med Chem Lett; 2004 Jun; 14(11):2797-800. PubMed ID: 15125935
[TBL] [Abstract][Full Text] [Related]
4. O-(2-dialkylaminoethyl)oximes of 5-(arylmethylene)-1,3,3-trimethyl-2-oxabicyclo [2.2.2]octan-6-ones with hypotensive, antiarrhythmic and other activities.
Mariani E; Bargagna A; Longobardi M; Schenone P; D'Amico M; Filippelli W; Falciani M; Filippelli A
Farmaco; 1994 Apr; 49(4):267-70. PubMed ID: 8049006
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of ketoximino-esters and -ethers as antihypertensive agents.
Kochhar MM; Williams BB; Fan JH
J Pharm Sci; 1969 Nov; 58(11):1382-4. PubMed ID: 5349754
[No Abstract] [Full Text] [Related]
6. N-substituted O-(3-amino-2-hydroxypropyl)oximes of 1,3,3-trimethyl-5-endo-(1-piperidinyl or 4-morpholinyl)-2-oxabicyclo [2.2.2]-octan-6-ones with platelet antiaggregating and local anesthetic activities.
Schenone S; Bruno O; Ranise A; Bondavalli F; D'Amico M; Parrillo C; Lampa E; Rossi F
Farmaco; 1992 Oct; 47(10):1249-62. PubMed ID: 1482516
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological activities of 7-azaindole derivatives.
Mushtaq N; Saify ZS; Noor F; Takween S; Akhtar S; Arif M; Khan KM
Pak J Pharm Sci; 2008 Jan; 21(1):36-9. PubMed ID: 18166517
[TBL] [Abstract][Full Text] [Related]
8. [Some new derivatives of aromatic oximes with beta-blocking activity].
Martani A; Magli M; Orzalesi G; Selleri R
Farmaco Sci; 1975 May; 30(5):370-9. PubMed ID: 240738
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: novel p38 MAP kinase inhibitors.
Laufer SA; Ahrens GM; Karcher SC; Hering JS; Niess R
J Med Chem; 2006 Dec; 49(26):7912-5. PubMed ID: 17181176
[TBL] [Abstract][Full Text] [Related]
10. [Substances with potential cardiovascular action. 2-acylaminobenzimidazoles with hypotensive activity].
Bellasio E; Campi A; Trani A; Baldoli E; Caravaggi AM; Nathansohn G
Farmaco Sci; 1973 Feb; 28(2):164-82. PubMed ID: 4692791
[No Abstract] [Full Text] [Related]
11. O-[2-hydroxy-3-(dialkylamino)propyl]ethers of (+)-1,7,7-trimethyl bicyclo[2.2.1]heptan-2-one oxime (camphor oxime) with analgesic and antiarrhythmic activities.
Schenone S; Bruno O; Ranise A; Bondavalli F; Filippelli W; Falcone G; Rinaldi B
Farmaco; 2000; 55(6-7):495-8. PubMed ID: 11204752
[TBL] [Abstract][Full Text] [Related]
12. Studies on quinoxaline derivatives. Synthesis of quinoxalylamino-1,3-diazacycloalkanes with potential hypotensive activity.
Foks H; Wisterowicz K; Nasal A; Damasiewicz B; Radwańska A
Acta Pol Pharm; 1999; 56(3):201-6. PubMed ID: 10635359
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-ones.
Alagarsamy V; Pathak US
Bioorg Med Chem; 2007 May; 15(10):3457-62. PubMed ID: 17391966
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates.
Chikhale RV; Bhole RP; Khedekar PB; Bhusari KP
Eur J Med Chem; 2009 Sep; 44(9):3645-53. PubMed ID: 19321237
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, spectral, crystal and antimicrobial studies of biologically potent oxime ethers of nitrogen, oxygen and sulfur heterocycles.
Parthiban P; Aridoss G; Rathika P; Ramkumar V; Kabilan S
Bioorg Med Chem Lett; 2009 Jun; 19(11):2981-5. PubMed ID: 19419867
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
Pinna GA; Loriga M; Curzu MM; D'Amico M
Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of 4a-methyl-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-ones.
Pinna GA; Salis E; Berta D; Gavini E; D'Amico M
Farmaco; 1997 Jan; 52(1):29-33. PubMed ID: 9181678
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, stereochemistry, and antimicrobial evaluation of substituted piperidin-4-one oxime ethers.
Ramalingan C; Park YT; Kabilan S
Eur J Med Chem; 2006 Jun; 41(6):683-96. PubMed ID: 16600438
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and hypotensive activity of some heterocyclic analogues of GYKI-12 743.
Mátyus P; Kasztreiner E; Diesler E; Behr A; Varga I; Kosáry J; Rabloczky G; Jaszlits L
Arch Pharm (Weinheim); 1994 Sep; 327(9):543-6. PubMed ID: 7979923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
